SynuCa Therapeutics

European Union (EU)
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.
Founded by
Investors:
BioInnovation Institute Venture Lab
$
Pre-seed
526075
Medical
Neuroscience
Therapeutics
Biotechnology
Health Care
Science and Engineering
Description:
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.
Key Metrics:
Total Raised
526075
Team Size
1-10
Location
Aarhus
Denmark
Last Funding
February 25, 2025
Contacts:
Email
Linkedin
Facebook